Anemia at Diagnosis in Pediatric Solid Tumors: Prevalence, Severity, and Hematologic Patterns: A Single-center Retrospective Study

Abstract

Introduction

Anemia is a frequent clinical finding at the time of diagnosis in children with solid tumors and may reflect tumor biology, nutritional status, or bone marrow involvement. However, the pattern and severity of anemia across different solid tumor types in children remain underreported.

Objective

The aim of this study was to evaluate the prevalence and characteristics of anemia at presentation among pediatric patients with various solid tumors.

Materials and Methods

This retrospective observational study included 149 children with newly diagnosed solid tumors, aged 0 to 18 years. Anemia was classified based on the World Health Organization age-specific hemoglobin thresholds and further categorized into mild, moderate, and severe grades. Tumors were classified into bone tumors, central nervous system (CNS) tumors, abdominal tumors, soft tissue sarcomas, germ cell tumors, and others. Associations between anemia and tumor type were analyzed using descriptive statistics and chi-square tests.

Results

Anemia was present in 67 (45%) patients at diagnosis. Bone tumors detected in 52 patients (34.9%) and CNS tumors detected in 34 patients (22.8%) were the most common malignancies. Among those with anemia, 36.4% had mild, 45.5% moderate, and 18.2% severe anemia. Statistical analysis revealed a significant association between red cell indices (mean corpuscular volume, mean corpuscular hemoglobin [MCH], red cell distribution width [RDW], mean corpuscular hemoglobin concentration) and anemia status (p < 0.001), with low MCH and high RDW suggesting the anemia was predominantly microcytic and hypochromic, with substantial anisocytosis.

Conclusion

Anemia is a common presenting feature in pediatric solid tumors. Detailed investigations to delineate the etiology of anemia are necessary to guide targeted management of the tumor as well as to correct the anemia.

Keywords

anemia - prevalence - red cell indices - pediatric

Authors' Contributions

V.B.K. conceptualized and designed the study and contributed to manuscript preparation and editing. S.P.M. contributed to the literature search, data acquisition, data analysis, manuscript preparation, and editing. A.M. was involved in data acquisition and analysis. N.S. contributed to data analysis and statistical analysis. A.M.V., E.A.R., S.B., and S.L.K. provided intellectual input and reviewed the manuscript. All authors have contributed to the manuscript in significant ways and have reviewed and agreed upon the manuscript content.

Patient Consent

Consent waiver was obtained from IEC as this was a retrospective study.

Publikationsverlauf

Artikel online veröffentlicht:
15. Oktober 2025

• References

• 1 Hufnagel DH, Bos LM, Brown AJ, Prescott LS. Compliance with NCCN guidelines for evaluation and treatment of anemia among patients with solid tumors. J Natl Compr Canc Netw 2024; 22 (03) e237108
• 2 Fan H, Su Y, Duan C. et al. Iron deficiency in children at the time of initial neuroblastoma diagnosis. Pediatr Investig 2019; 4 (01) 17-22
• 3 Gilreath JA, Rodgers GM. How I treat cancer-associated anemia. Blood 2020; 136 (07) 801-813
• 4 World Health Organization. Guideline on Haemoglobin Cutoffs to Define Anaemia in Individuals and Populations. Geneva: World Health Organization; 2024
• 5 International Institute for Population Sciences (IIPS) and ICF. . National Family Health Survey (NFHS-5), 2019–21: India. Vol. I. Mumbai: IIPS; 2021 . Accessed June 11, 2025, at: http://www.rchiips.org/nfhs
• 6 Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 2004; 116 (Suppl 7A): 11S-26S
• 7 Hockenberry MJ, Hinds PS, Barrera P. et al. Incidence of anemia in children with solid tumors or Hodgkin disease. J Pediatr Hematol Oncol 2002; 24 (01) 35-37
• 8 Ruggiero A, Riccardi R. Interventions for anemia in pediatric cancer patients. Med Pediatr Oncol 2002; 39 (04) 451-454